Allo HSCT with RIC for poor-risk CLL in Sweden: donor T-cell engraftment 3 months after transplantation predicts long-term survival

被引：0
|
作者：
Hagglund, H. [1 ]
Machaczka, M. [1 ]
Remberger, M. [1 ]
Hallbook, H. [2 ]
Lazarevic, V. [4 ]
Wahlin, A. [3 ]
Malm, C. [5 ]
Kimby, E. [1 ]
Johansson, J-E [6 ]
机构：
[1] Hematol Ctr, Stockholm, Sweden
[2] Dept Hematol, Uppsala, Sweden
[3] Dept Hematol, Umea, Sweden
[4] Dept Hematol, Lund, Sweden
[5] Dept Hematol, Linkoping, Sweden
[6] Dept Hematol, Gothenburg, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [1] T-cell infiltrate predicts long-term survival in CRC
    Lisa Hutchinson
    [J]. Nature Reviews Clinical Oncology, 2009, 6 (11) : 616 - 616
  • [2] Poor engraftment at 3 months predicts for poor survival following autologous peripheral blood stem cell transplantation.
    Pratt, G
    Rawstron, AC
    Child, JA
    Morgan, GJ
    Smith, GM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 59 - 59
  • [3] Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival
    Khan, SA
    Gaa, B
    Pollock, BH
    Shea, B
    Reddy, V
    Wingard, YR
    Moreb, JS
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (08) : 433 - 438
  • [4] Functional outcome 3 months after stroke predicts long-term survival
    Eriksson, Marie
    Norrving, Bo
    Terent, Andreas
    Stegmayr, Birgitta
    [J]. CEREBROVASCULAR DISEASES, 2008, 25 (05) : 423 - 429
  • [5] Improved Gvhd Free, Relapse Free Survival Using Dual T-Cell Depletion with ATG and Ptcy in Matched Unrelated Donor RIC Allo-HSCT
    Salas, Maria Queralt
    Lam, Wilson
    Law, Arjun
    Michelis, Fotios V.
    Kim, Dennis Dong Hwan
    Al-Shaibani, Zeyad
    Loach, David
    Lipton, Jeffrey H.
    Kumar, Rajat
    Mattsson, Jonas
    Viswabandya, Auro
    [J]. BLOOD, 2019, 134
  • [6] LONG-TERM DISEASE-FREE SURVIVAL IN MANTLE CELL LYMPHOMA (MCL) PATIENTS FOLLOWING REDUCED INTENSITY CONDITIONING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (RIC ALLO-HSCT)
    Constantinou, V.
    Batsis, I.
    Kaloyannidis, P.
    Mallouri, D.
    Yannaki, E.
    Iskas, M.
    Sakellari, I.
    Anagnostopoulos, A.
    [J]. HAEMATOLOGICA, 2013, 98 : 669 - 669
  • [7] Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
    Machaczka, Maciej
    Johansson, Jan-Erik
    Remberger, Mats
    Hallbook, Helene
    Malm, Claes
    Lazarevic, Vladimir Lj
    Wahlin, Anders
    Omar, Hamdy
    Juliusson, Gunnar
    Kimby, Eva
    Hagglund, Hans
    [J]. LEUKEMIA & LYMPHOMA, 2012, 53 (09) : 1699 - 1705
  • [8] SEQUENTIAL QUANTIFICATION OF T-CELL RECEPTOR EXCISION CIRCLES (TREC) PREDICTS LONG-TERM OUTCOMES OF EARLY SURVIVORS AFTER ALLOGENEIC HSCT
    De Miguel Jimenez, Carlos
    Brianso, Ferran
    Alonso, Rosalia
    Esther Martinez-Munoz, Maria
    Bautista, Guiomar
    Manchado-Perdiguero, Carlos
    Antonio Garcia-Marco, Jose
    Sanchez-Peral, Ali
    Duarte, Rafael
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 465 - 465
  • [9] LONG-TERM SURVIVAL AFTER T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Linker, A.
    Goldberg, J. D.
    Ratan, R.
    Jurcic, J.
    Barker, J. N.
    Castro-Malaspina, H.
    Jakubowski, A. A.
    Jenq, R.
    Koehne, G.
    Papadopoulos, E.
    van den Brink, M. R. M.
    Young, J. W.
    Boulad, F.
    Kernan, N. A.
    O'Reilly, R. J.
    Small, T. N.
    Heller, G.
    Perales, M. A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S250 - S250
  • [10] Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning (RIC) allogeneic stem cell transplantation (Allo-SCT)
    Mohty, M
    Avinens, O
    Faucher, C
    Furst, S
    Viens, P
    Gastaut, JA
    Eliaou, JF
    Blaise, D
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 33 - 33
12345